Gufic BioSciences Q2 Results
- BSE: 509079
- NSE: GUFICBIO
- ISIN: INE742B01025
- Sector: Biotechnology & Drugs
BSE
302.20
-0.45 (-0.15%)
-0.45 (-0.15%)Volume1.53 K
Updated: Fri 17 Apr, 2026 | 15:18:09
NSE
300.60-1.85 (-0.61%)
-1.85 (-0.61%)Volume51.84 K
Updated: Fri 17 Apr, 2026 | 15:25:44
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Gufic BioSciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 206.98 | 198.14 | 4.46% | 169.86 | 21.85% |
| Depreciation/ Amortization | 7.77 | 7.72 | 0.70% | 4.30 | 80.86% |
| Operating Income | 30.07 | 25.58 | 17.55% | 34.32 | -12.37% |
| Net Income | 16.82 | 13.07 | 28.72% | 21.77 | -22.71% |
| Other Operating Expenses Total | 57.32 | 53.65 | 6.83% | 40.96 | 39.93% |
| Net Income Before Taxes | 22.60 | 17.27 | 30.86% | 29.25 | -22.73% |
| Total Revenue | 237.05 | 223.72 | 5.96% | 204.18 | 16.10% |
| Selling/ General/ Admin Expenses Total | 37.45 | 36.00 | 4.04% | 28.47 | 31.53% |
| Diluted Normalized EPS | 1.68 | 1.30 | 29.23% | 2.17 | -22.58% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.